Publisher's Synopsis
In this review of current literature we see a convergence of biological targets and candidate medicines for cancer's fermentative metabolism, reprogramming of its genetics, development of stem cell properties and evasion and corruption of the immune system. Included are details how these remedies may interact with standard cancer care, cautions and contraindications. New concepts in monitoring the success of interventions are also revealed.
Integrating natural adjuncts improves quality of life and outcomes for cancer patients.
